You are here:
02 June 2017 / article

Borderline products: Cranberry products cannot be regarded as medical devices

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Decision on the qualification of cranberry products.

According to the Decision, cranberry products do not fall within the definition of medical devices set out in the Medical Devices Directive.  

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Implementing Decision on the qualification of cranberry products. The Decision states that products “whose principal intended action, depending on proanthocyanidins present in cranberry (Vaccinium Macrocarpon)extract, is to prevent or treat cystitis”, are not medical devices within the meaning of Article 1 (2) (a) of the Medical Devices Directive.

Pharmacological and not a mechanical

The Decision was taken upon the request from France in accordance with Article 13 (1) (d) of the Medical Devices Directive. It also follows the European Medicines Agency’s (EMA) scientific opinion of 22 July 2016 which noted that “Products containing proanthocyanidins and/or cranberry as substance or preparation for use in urinary tract infections are currently marketed differently across the EU as food supplement, medical device or consumer product”. Furthermore, EMA concluded that the principal intended action of this group of products is most probably pharmacological and not a mechanical mode which would qualify them as medical devices.

Food supplements or medicinal products?

It will nevertheless be up to the Members States’ competent authorities to determine whether these products are food supplements or medicinal products. Should they be considered as food supplements, all health-related communications regarding those products will fall within the scope of the Nutrition and Health Claims Regulation.

The formal adoption and publication of the Decision are planned later this summer.



Real Estate Quarterly - July 2018

Real Estate Quarterly - July 2018

We produce a quarterly newsletter to keep you updated on legal developments and important trends in the real estate sector. read more
When your company invites its customers for an exclusive World Cup event:

When your company invites its customers for an exclusive World Cup event: what does it actually cost?

Belgium has qualified for the World Cup semi-finals and the Belgian company BeerCo wants to invite some of its best customers to attend an exclusive World Cup... read more
Court of Justice condemns Belgian system for disregarding the A1 Declaration

Court of Justice condemns Belgian system for disregarding the A1 Declaration

On 11 July 2018, the Court of Justice issued an important ruling in the case C-356/15 European Commission versus Belgium. The Court of Justice ruled that... read more